NasdaqCM - Delayed Quote • USD
First Wave BioPharma, Inc. (FWBI)
At close: May 13 at 4:00 PM EDT
After hours: May 13 at 7:18 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -2.43 | -0.32 | -1.8 | -1.55 |
| Low Estimate | -2.43 | -0.32 | -1.8 | -1.55 |
| High Estimate | -2.43 | -0.32 | -1.8 | -1.55 |
| Year Ago EPS | -36.4 | -37.8 | -47.88 | -1.8 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -42.6 | -20.8 | -12.3 | -4.03 |
| EPS Actual | -36.4 | -37.8 | -9.2 | -5.35 |
| Difference | 6.2 | -17 | 3.1 | -1.32 |
| Surprise % | 14.60% | -81.70% | 25.20% | -32.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -2.43 | -0.32 | -1.8 | -1.55 |
| 7 Days Ago | -2.43 | -0.32 | -1.8 | -1.55 |
| 30 Days Ago | -2.41 | -0.96 | -3.59 | -1.55 |
| 60 Days Ago | -2.27 | -1.29 | -5.33 | -3.99 |
| 90 Days Ago | -2.27 | -1.29 | -5.33 | -3.99 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | FWBI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 93.30% | -- | -- | 8.30% |
| Next Qtr. | 99.20% | -- | -- | 11.90% |
| Current Year | 96.20% | -- | -- | 5.60% |
| Next Year | 13.90% | -- | -- | 13.00% |
| Next 5 Years (per annum) | -- | -- | -- | 11.05% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Roth MKM: Buy to Buy | 3/15/2024 |
| Maintains | Roth MKM: Buy to Buy | 1/3/2024 |
Related Tickers
ENSC Ensysce Biosciences, Inc.
0.5850
+10.65%
PBLA Panbela Therapeutics, Inc.
0.4061
+6.92%
KPRX Kiora Pharmaceuticals, Inc.
0.5097
+3.60%
MLTX MoonLake Immunotherapeutics
41.71
+1.93%
PXMD PaxMedica, Inc.
0.2288
+10.53%
CPMV Mosaic ImmunoEngineering, Inc.
0.4000
+5.50%
PALI Palisade Bio, Inc.
6.22
-7.30%
QNRX Quoin Pharmaceuticals, Ltd.
0.7894
+2.16%
ONCO Onconetix, Inc.
0.1134
+6.98%
SPRC SciSparc Ltd.
1.2500
0.00%